TotalMarketCap

Turn Therapeutics

TTRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$272.657 M

$8.93 -8.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Turn Therapeutics (TTRX) has a market capitalization of $272.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$3.19M

Loss-making

Shares outstanding

29,788,040

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #222Fulcrum TherapeuticsFULC$281.5M
  2. #223VogenxVOGX$273.8M
  3. #224Turn TherapeuticsTTRX$272.7M
  4. #225Rocket PharmaceuticalsRCKT$267.3M
  5. #226Arcturus TherapeuticsARCT$266.9M

What if Turn Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$924,807.50

Per share 103,562× higher

Bitcoin $1.53T

$50,039.72

Per share 5,604× higher

Apple $5.02T

$164,275.74

Per share 18,396× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Turn Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.